ID: ALA223472

Max Phase: Preclinical

Molecular Formula: C11H14IN5O5

Molecular Weight: 423.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CONc1nc(I)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C11H14IN5O5/c1-21-16-8-5-9(15-11(12)14-8)17(3-13-5)10-7(20)6(19)4(2-18)22-10/h3-4,6-7,10,18-20H,2H2,1H3,(H,14,15,16)/t4-,6-,7-,10-/m1/s1

Standard InChI Key:  GNNGFDUNVSCVFX-KQYNXXCUSA-N

Associated Targets(Human)

Adenosine A1 receptor 17603 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A2a receptor 16305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A3 receptor 15931 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine receptors; A1 & A3 1051 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine receptors; A2a & A3 373 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 423.17Molecular Weight (Monoisotopic): 423.0040AlogP: -0.98#Rotatable Bonds: 4
Polar Surface Area: 134.78Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.29CX Basic pKa: 0.24CX LogP: -0.33CX LogD: -0.33
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.28Np Likeness Score: 0.92

References

1. Volpini R, Dal Ben D, Lambertucci C, Taffi S, Vittori S, Klotz KN, Cristalli G..  (2007)  N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.,  50  (6): [PMID:17309246] [10.1021/jm060963u]

Source